Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...
Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and ...
Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...
“Although rare, ILD and CIDP development shortly after COVID-19 vaccine administration is well documented within the literature,” the researchers said. “However, a pathologic link has yet to be ...
The fall virus season is upon us, and the U.S. Food & Drug Administration just approved one of the newest tools to protect ...
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...
The PCMPA has slammed Moderna over an unapproved WhatsApp message that offered children 1,500 pounds sterling ($2,000) to ...
Vaccine skeptics have said changes were introduced to "accommodate" the shortcomings of the COVID-19 vaccines.
Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...
Sage Memorial Hospital (SMH) is pleased to announce the schedule for the 2024 mass flu and COVID vaccine event. This ...
Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback